“…These results were supported by the study by Ebbing et al, (2019), in which the pro-inflammatory cytokines TNF-a, Il-6, and IL-1Β that is a prognostic markers for breast cancer progression (Templeton et al, 2015) as they stimulate angiogenesis that aids its growth, these cytokines are produced by tumor cells and stromal cells in many cancers that lead to the development of drug resistance and metastasis (Hernandez-Vargas et al, 2020), this explains the reason for the high level of IL-1Β in patients with breast cancer, and the high level at the age of ≥50, post-menopause, is due to run away adipokines, cytokines, IL-1β, IL-6, TNFα, and chemokines such as IL-8 and MCP-1 is from adipose tissue and this has a role in cancer development (Lee et al, 2007), adipose tissue also increases the level of estrogen induced by aromatase activity (Awatef et al, 2011). Studies have shown that the risk of developing breast cancer increases by 40% for every 10 increase in body mass post-menopause that fibroblasts in old age acquire "Secretory phenotype associated with aging" (SASP), which causes the production of pro-inflammatory cytokines (IL-6, IL-1β), chemokines (IL-8, MCP-1, GRO-1/α), MMPs, integrins, and adhesion molecules (Szulc-Kielbik and Klink, 2022). The results of Table (2) showed that there were no significant differences in the expression of IL-1β at different levels of Grads, and the results showed that the expression was increased with the highest grades and that the highest expression was recorded in grade III, the result was (2218.337± 14.000, 12134.45± 1662.146, 22391.55± 2.996) in grade I, II, III respectively under the probability level (p≤ 0.05).…”